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Objective: To describe hypertensive patients’ experiences with sexual side effects and their 
consequences for antihypertensive medication adherence.
Methods: Data were from a study conducted to identify facilitators of and barriers to adher-
ence to blood pressure-lowering regimens. Participants were 38 married and unmarried veterans 
with a diagnosis of hypertension and 13 female spouses. Eight patient and four spouse focus 
groups were conducted. A directed approach to content analysis was used to determine the 
facilitators of and barriers to adherence. For this report, all discussion concerning the topic of 
sexual relations was extracted.
Results: Male patients viewed sexual intercourse as a high priority and felt that a lack of 
sexual intercourse was unnatural. They pursued strategies to preserve their potency, includ-
ing discontinuing or selectively adhering to their medications and obtaining treatments for 
impotence. In contrast, spouses felt that sexual intercourse was a low priority and that a lack 
of sexual intercourse was natural. They discouraged their husbands from seeking treatments 
for impotence.
Conclusion: Although the primary study was not designed to explore issues of sexual 
function, the issue emerged spontaneously in the majority of discussions, indicating that 
sexuality is important in this context for both male patients and their spouses. Physicians 
should address sexual side effects of antihypertensive medications with patients, ideally 
involving spouses.
Keywords: hypertension, sexual side effects, antihypertensive medication, adherence, blood 
pressure
Despite the positive effects of pharmacological, diet, and exercise interventions to reduce 
blood pressure (BP), less than one-third of hypertensive patients achieve adequate BP 
control as deﬁ  ned by Joint National Committee VII guidelines (Burt et al 1995; Hajjar 
and Kotchen 2003). A major barrier to adequate BP control is patient nonadherence 
to medication and failure to institute recommended lifestyle changes. An estimated 
20%–80% of patients diagnosed with hypertension do not take their medications as pre-
scribed (Dunbar-Jacob et al 1995; Ogden et al 2006), and nearly 75% of Americans do 
not adhere to recommended hypertension lifestyle changes such as the DASH (Dietary 
Approaches to Stop Hypertension) diet (Brownell et al 1986; Mellen et al 2008).
Several qualitative and quantitative studies have been conducted to investigate 
reasons for nonadherence to antihypertensive medications, focusing on aspects of 
patients, the disease, and the medications themselves. For example, patients may not 
take antihypertensive medications as prescribed because they do not experience any 
adverse symptoms and feel well (Ogedegbe et al 2004). Additionally, patients may not Patient Preference and Adherence 2008:2 202
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wish to take medication indeﬁ  nitely or may simply forget to 
take their medications at times (Svensson et al 2000). Com-
mon reasons related to the medications include patients’ 
beliefs about the necessity or efﬁ  cacy of the medication, 
dosing frequency, regimen complexity, and side effects 
(Svensson et al 2000; Safren et al 2001; Benson and Britten 
2002; Ogedegbe et al 2004).
Previous studies are limited because researchers have 
conceptualized side effects in a uniform fashion, rather than 
distinguishing different side effects and how they may affect 
adherence. Patients may be willing to live with some side 
effects and not others and, therefore, some side effects may 
have an impact on adherence to a greater degree.
Another limitation is that in previous studies, the role 
that spouses play has not been investigated. Although it 
is often assumed that spouses enhance adherence, spouses 
can also do things to decrease adherence, such as nagging, 
punishing the spouse for engaging in undesired behaviors, 
or requesting the spouse to engage in a speciﬁ  c behavior 
(Umberson 1987; Tucker and Mueller 2000). Thus, spouses 
may inﬂ  uence whether patients live with speciﬁ  c side effects 
or pursue avenues to ameliorate them.
In this paper, the results are reported of a secondary 
data analysis of older hypertensive patients’ experiences 
with sexual side effects and their consequences for antihy-
pertensive medication adherence. We report also spouses’ 
perceptions of the effect of sexual side effects on patients. 
Understanding patients’ experiences with sexual side effects 
and medication adherence can help identify opportunities for 
clinical intervention.
Methods
Design, setting, and participants
The data for this study were obtained from a larger study 
designed to understand the spouses’ role in the self-
management of  hypertension. The larger study was approved 
by the Institutional Review Board at the Durham Veterans 
Affairs Medical Center. We mailed recruitment letters to a 
random sample of  233 patients diagnosed with hypertension 
(ICD-9 code 401.9) receiving care from the Durham Veterans 
Affairs Medical Center. Approximately two weeks later, a 
research assistant attempted to reach patients by telephone. 
We were able to contact 66 patients, of whom 38 (37 males, 
1 female) were scheduled for a focus group. Patients who 
agreed were asked if they had a spouse or signiﬁ  cant other 
who would be willing to participate in a separate focus group. 
The research assistant spoke to 24 female spouses, of whom 
13 were scheduled for a focus group.
Data collection
Eight patient groups were convened, with an average of 
4 patients per group. Four spouse groups were convened, with 
an average of 3 spouses per group. A female social worker 
moderated the patient groups, and a female social psycholo-
gist moderated the spouse groups, which occurred concur-
rently in a different room. After obtaining informed consent, 
the moderator administered a demographic questionnaire 
to assess biological sex, race, age, and marital status. The 
moderator began each discussion by asking which changes 
patients were asked to make at and since diagnosis. As the 
discussion unfolded, the moderator asked what was easy or 
difﬁ  cult about making those changes and about the spouses’ 
role. Participants were probed about medication, diet, exer-
cise, and stress. Participants spontaneously mentioned sexual 
side effects when discussing medications. Accordingly, the 
medication questions from the patient and spouse moderator 
guides are shown in Table 1. To ensure exhaustiveness of 
responses, we conducted patient and spouse groups until the-
matic saturation was obtained (Strauss and Corbin 1998).
Data analysis
All discussions were audiotaped and transcribed. We used a 
directed approach to content analysis to determine the facili-
tators of and barriers to adherence (Hsieh and Shannon 2005). 
The directed approach is appropriate when some research 
exists about a phenomenon, but a researcher wishes to obtain 
more descriptive information. In coding the transcripts, one 
team member generated one or more descriptive labels to 
describe elements of adherence. A second team member 
generated descriptive labels for a subset of the transcripts. 
The coding scheme was ﬁ  nalized through discussion. Then, 
the coding scheme was applied to all transcripts by one team 
member. Across all transcripts, a list of twenty elements was 
generated, one of which was sexual relations. For the current 
analysis, we extracted all discussions associated with sexual 
relations as a factor inﬂ  uencing medication adherence. We 
report the most representative quotes in a case-oriented 
fashion (by age, race, and marital status) to show the range 
of individuals who espoused these views.
Results
All but one patient were male, 45% were white, 50% were 
black, and 74% were married (see Table 2). All spouses were 
female, 62% were white, and 31% were black.
When discussing side effects of antihypertensive medica-
tions, discussion turned spontaneously to sexual relations in 5 of 
the 8 patient groups (including the group with the sole female Patient Preference and Adherence 2008:2 203
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Table 1 Patient and spouse questions about medication
Patient Questions
Thinking back to when you were diagnosed, I’d like you to tell us what changes you made to your lifestyle and what things you didn’t change.   Also, I’d 
like you to comment on what was difﬁ  cult to do, what was easy to do, and what has helped you make those changes.
•  Tell me about the role medication plays in managing your high blood pressure.
•  What things help you take your medications as prescribed?
  {  What role do your family and friends play?
  {  Does someone remind you to take your medication? If so, who? How often?
•  What things prevent you from taking your medications as prescribed?
  {  Discuss the role of memory.
  {   Some high blood pressure medications are associated with side effects. I’d like you to talk about your experience with side effects and how 
they may affect whether you take your medication.
•  How do you feel about taking medication?
  {   In a chronic condition like high blood pressure, people often have to take medication for several years, even for the rest of their lives.   What are 
your thoughts about that?
Spouse Questions
Think back to when you found out that the person you live with had high blood pressure. Tell us a little bit about that: when they were diagnosed, 
what your initial reaction was, and what changes they said they had to make.
•  Tell me about the role medication plays in your relative or partner’s treatment for high blood pressure.
•  What things help your relative or partner take their medication as prescribed?
  {  What role do you play?
  {  How often do you help your relative or partner with medication?
  {  What role do others play, such as other family members and friends?
patient; she contributed to the discussion) and 3 of the 4 spouse 
groups. These groups were similar in composition to those 
groups in which sexual relations was not discussed in number 
of participants per group, race, age, and, for patients, marital 
status. Patient and spouse themes are shown in Table 3.
Patients’ views
The male patients felt that sexual activity reduced stress 
caused by high blood pressure. As a 71-year-old, white, 
married man said: “If you don’t get a full balance, it will 
send your blood pressure sky high. Sex lowers your blood 
pressure at times.” A 73-year-old, black, separated man said: 
“I think that’s [sexual intercourse] what I need. I think my 
blood pressure would go down to about 110/60.”
Along with the belief that sexual intercourse would 
lower blood pressure were the views that sexual intercourse 
was a high priority and that a lack of sexual intercourse was 
unnatural. As a 51-year-old, black, married man observed: 
“I’ll be honest with you. It [sexual intercourse] is part of 
your makeup. It’s part of your physical make up, part of your 
spiritual make up, it’s part of your mental make up, and you 
need to get you some. And I have learned that. And don’t 
stress yourself out by not. I’m too old for that.”
Patients felt that antihypertensive medications interfered 
with their desire and ability to have sexual intercourse. This 
perception made patients, married and unmarried, pursue 
strategies to preserve sexual function. One strategy was 
to ask their providers for phosphodiesterase-5 (PDE-5) 
inhibitors. Not all patients did this, however. For example, 
the 73-year-old, black, separated man commented that “the 
medications wreak havoc on the libido” but would not take 
a PDE-5 inhibitor. He believed that: “Viagra is a rattlesnake. 
I know people who have died from taking it.”
A second strategy was to obtain a penile implant, as 
discussed by two male patients. One of them, a 71-year-old, 
white, married man, reported being “happy to say I wore it 
out after 7 years” and had the implant replaced.
The most commonly discussed strategies concerned use of 
antihypertensive medication. These strategies took two forms. 
First, patients would discontinue their medication and later 
ask the physician for a medication without sexual side effects, 
as indicated by a 53-year-old, black, married man: “I did stop 
one time because it was interfering with my sex life, and I’m 
a married man and I couldn’t have that. So I stopped taking 
it until I got a chance to come back to the doctor.”
A second medication-taking strategy was to selectively 
adhere to antihypertensive medications. A 58-year-old, black, 
separated man explained: “Sometimes taking the medica-
tion can be difﬁ  cult, in the sense that it affects your sexual 
arousal and sometimes I’m tempted to—If  I know I’m going 
to have an encounter coming up a day or two from now or 
something, I might not take it for that day, the day before. 
Once in a while I skip that day, and then pick back up on it 
after the encounter is over.”Patient Preference and Adherence 2008:2 204
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Although the dominant view among patients was that 
selective adherence to preserve sexual activity was acceptable 
and even necessary, a few male patients felt that the tradeoff 
was not worth it. That is, they felt that there would be serious 
consequences if they did not adhere and, therefore, continued 
to take their medication as prescribed.
Spouses’ views
Spouses in our study conﬁ  rmed that men were bothered 
by sexual side effects of the antihypertensive medications. 
A 79-year-old, white, married woman described it as 
“probably the most serious side effect of the medication.” 
In contrast to patients, however, spouses portrayed sexual 
intercourse as a low priority, with a lack of sexual intercourse 
as a natural consequence of aging, emerging health problems, 
and many years of marriage. A 63-year-old black, married 
woman, noted: “He feels like he’s supposed to be just like 
he was in 1960 when we got married, and I can’t convince 
him that he’s not [another woman chuckles knowingly]. He’s 
70-years-old now, and I’m 63. And I mean, you know, hey! 
Once a year is all right, you know [laughs]? I’m serious! But 
he hasn’t accepted that, and I can tell he hasn’t.”
Similarly, the 79-year-old, white, married woman indi-
cated that her marriage had not been affected by the sexual 
dysfunction, as she noted: “That hasn’t affected our marriage, 
as I can see. As a matter of fact, we seem to be very close. 
Maybe the older we’ve gotten, the closer we’ve gotten, more 
maybe dependent on each other.”
Instead of focusing on the sexual effects of medications, 
spouses thought their husbands should focus on their health 
and longevity. As the 63-year-old black, married woman 
observed: “Just be thankful that you’re still alive! Don’t 
dwell on what you can or can’t do.”
A 53-year-old, black, married woman tried to persuade 
her husband to discuss impotence with his physician, but 
he was ashamed to do so: “Since he started this medication, 
you know, he doesn’t want to talk about it. His sexual func-
tion goes down, but he doesn’t want to talk about it. It is a 
personal thing and he won’t talk about it. But I told him that, 
you know, when the doctor asks you, ‘Have you had any 
changes?’ or, ‘Can you sleep?’ You have to tell your doctor 
what is going on. He knew that’s one of the side effects. He’s 
kind of ashamed about talking about it.”
Although the dominant idea among spouses was that 
sexual intercourse was a low priority and that a decrease in 
the frequency of sexual intercourse was natural, there was 
one exception. The 63-year-old black, married woman was 
bothered by the decrease in sexual activity, but she did not 
want to admit that to her husband. As she reported: “I say 
I’m doing okay, I’m alright, don’t worry about me. Maybe 
sometimes I have to lie, but it’s okay too. The Lord knows 
about that [chuckles]. Because I don’t want to do anything 
that’s going to upset him and cause his blood pressure to go 
up higher. So sometimes I pretend. It’s not that often, but 
sometimes I have to pretend that I’m okay.”
This spouse saw herself as insulating him against further 
stress, which would cause his blood pressure to rise: “If it’s 
going to make him well and feel good and blood pressure 
Table 3 Patient and spouse themes regarding sexual function and 
adherence
Patient themes Spouse themes
Sexual intercourse is a high 
priority
Sexual intercourse is a low priority
Decrease in the frequency 
of sexual intercourse is abnormal
Decrease in the frequency of sexual 
intercourse is normal
Seeking treatment for impotence Discouraging patients from taking 
PDE-5 inhibitors
Selectively adhering to 
antihypertensive medications 
to preserve sexual function
Discouraging patients from skipping 
their antihypertensive medications
Table 2 Patient and spouse characteristics
Patients (N = 38)
Age M (SD); range 66.3 (11.0); 42–89
Sex N (%)
 Male 37  (97.4)
 Female 1  (2.6)
Race N(%)
 White 17  (44.7)
 Black 19  (50.0)
 Hispanic 1  (2.6)
 Asian 1  (2.6)
Marital status* N(%)
 Single 4  (10.5)
  Divorced or separated 5 (13.2)
 Married 28  (73.7)
Spouses (N = 13)
Age 66.8 (11.4); 48–82
Sex N(%)
 Female 13  (100)
Race N(%)
 White 8  (61.5)
 Black 4  (30.8)
 Asian 1  (7.7)
Note: *One patient did not report marital status.Patient Preference and Adherence 2008:2 205
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stay down, yes, I will lie and say I’m okay. Don’t worry 
about me.”
Whereas some male patients were willing to take PDE-5 
inhibitors to maintain sexual function, all spouses who men-
tioned these medications indicated that they were unnatural 
and unnecessary. The 63-year-old black, married woman 
described how she squelched her husband’s attempt to obtain 
a PDE-5 inhibitor, as follows: “Evidently the doctor asked 
him something about his sex drive. And I was called in, and 
the doctor asked me what I thought about him getting Viagra. 
Don’t need this stuff  ! Because I had heard that it caused 
cancer! You know, if you’re going to take something that’s 
going to make you have something that you don’t already 
have, why take it? Don’t ﬁ  x it if it’s not broke [laughter]. So 
I said that’s out! No Viagra comes to our house.”
She also noted that PDE-5 inhibitors were unnatural: 
“I feel that if it’s not natural, I don’t need it. You know, if 
he’s not able to perform like he has in the past or like he 
thinks he ought to have, I don’t need anything to boost him 
up. I mean, that’s artiﬁ  cial. That’s not being him.”
Discussion
In our study, male veteran patients with hypertension were 
bothered by impotence, which they attributed to their anti-
hypertensive medications. Moreover, they viewed sexual 
intercourse as a high priority and as a natural, expected part 
of  life. Accordingly, they engaged in strategies that allowed 
them to have sexual intercourse, including discontinuing 
their antihypertensive medications, selectively adhering 
to their antihypertensive medications, or obtaining treatment 
for impotence (ie, PDE-5 inhibitors or penile implants). In 
contrast to patients, spouses felt that sexual intercourse was 
not a high priority and that a decrease in sexual activity over 
time was natural. Moreover, spouses discouraged their hus-
bands from taking PDE-5 inhibitors to treat impotence.
These ﬁ  ndings extend previous research on adherence 
to antihypertensive medications in several ways. In most 
studies, side effects have been treated uniformly, with little 
attempt made to understand the different side effects and 
the ways in which they may affect adherence. Patients may 
be able to live with some side effects, but not with others. 
There were men in our study who were unwilling to live with 
impotence; consequently, some discontinued or selectively 
adhered to their antihypertensive medications. The men 
who pursued the latter strategy approached antihypertensive 
medications the way they would PDE-5 inhibitors; that is, 
on a dose-by-dose basis according to their expectations for 
having a sexual encounter. Men were bothered because they 
lost the ability to do something they enjoyed and that made 
them feel intimate with their partners.
Our ﬁ  ndings add to the literature on medication adher-
ence for asymptomatic chronic diseases such as hyperten-
sion (Osterberg and Blaschke 2005), which indicates that 
adherence is particularly challenging when patients do not 
feel symptoms and when the medications may make them 
feel worse. Men may not feel sick or experience symptoms 
of elevated blood pressure, but they will feel the effects of 
impotence. Persuading them to forego sexual activity, a high 
priority for them, in exchange for the possibility that they 
will not have a coronary event or stroke in the future may, 
therefore, be a challenging task. Occasionally missing or 
delaying a dose in order to have sexual intercourse may not 
pose a substantial cardiovascular risk. Yet, discontinuing a 
medication altogether can have perilous consequences. About 
15% of nonelective hospital admissions in the elderly are 
due to nonadherence to medications (Wyatt et al 2004), and 
strokes may occur due to discontinuation of antihyperten-
sive medications. Although one participant returned to his 
physician to ask for a different medication, not all patients 
will do this.
A strength of this study was the inclusion of female 
spouses, which allowed us to learn about the extent to which 
they agreed or disagreed with male patients. Spouses felt that 
men should prioritize reducing cardiovascular risk over main-
taining potency. To spouses, the cost of nonadherence—a 
potential cardiovascular event or death—was greater than 
the beneﬁ  t of maintaining a sexual relationship.
There were several limitations to this study. Patients and 
spouses were not asked speciﬁ  cally about sexual function; 
therefore, some groups did not discuss it. This may have 
been due to the personal nature of the issue, the reluctance 
to discuss it in a group setting, or the fact that the moderator 
was female. Alternatively, because sexual side effects are 
an issue for only some antihypertensive medication classes, 
and then for only a subset of patients who take those medica-
tions, some patients may not have experienced side effects 
and, therefore, had no need to discuss them. These design 
issues may have limited our ability to obtain a full range 
of experiences. Nonetheless, the fact that sexual function 
was discussed spontaneously in most of the groups and in 
such detail indicates that it is a signiﬁ  cant issue for many 
male patients, married and unmarried alike, as well as their 
spouses. A second limitation is that there was only one 
female patient, which did not allow us to examine differences 
between men and women. Given that the majority of  patients 
at our facility are male, the lack of representation of females Patient Preference and Adherence 2008:2 206
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was expected. Finally, as this study was exploratory rather 
than conﬁ  rmatory, it was not intended to generalize to all 
veterans or patients with hypertension. Rather, it was intended 
to uncover some of the difﬁ  culties that hypertensive patients 
have with medication adherence. To address these limitations, 
future research might employ survey methods to determine 
the prevalence of these views and the extent to which sexual 
dysfunction negatively impacts adherence in both men and 
women. Future research might also explore why spouses 
of men with hypertension may oppose treatment for sexual 
dysfunction (eg, is it due to fear of a heart attack?).
These findings may have practical implications for 
healthcare providers who treat men with hypertension. 
Discontinuation rates of antihypertensive agents are high, 
ranging from 30% to 40% over one year (Elliott et al 2007). 
A portion of those individuals may be discontinuing because 
of sexual side effects. Because preserving sexual function is 
important to many men, and some men may be embarrassed 
to bring up socially sensitive issues, clinicians should ask 
hypertensive patients about their experience with sexual 
side effects. Clinicians must then decide whether the impo-
tence is caused by the medications, hypertension, or other 
common underlying diseases such as diabetes mellitus. For 
some patients, clinicians may be able to prescribe a different 
medication class in the hope that sexual function returns. For 
patients with comorbid conditions, this may not be possible 
due to their health or interactions with other medications. 
In such cases, clinicians may consider prescribing a PDE-5 
inhibitor when there are no contraindications. Yet, as we 
learned in this study, this solution may be unacceptable to 
some spouses. Therefore, clinicians might consider involving 
spouses in conversations directly or encouraging patients to 
discuss treatment options with their spouses before deciding 
on a course of action.
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